ASX - By Stock
|
EMD |
Re:
Ann: Positive results received for Emyrias MDMA-inspired program
|
|
Billyandpop
|
45 |
9.0K |
3 |
20/08/22 |
20/08/22 |
ASX - By Stock
|
45
|
9.0K
|
3
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Positive results received for Emyrias MDMA-inspired program
|
|
Billyandpop
|
45 |
9.0K |
3 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
45
|
9.0K
|
3
|
|
ASX - By Stock
|
S2R |
Re:
Ann: Multiple new conductors identified at Polar Bear Project
|
|
Billyandpop
|
33 |
15K |
4 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
33
|
15K
|
4
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Positive results received for Emyrias MDMA-inspired program
|
|
Billyandpop
|
45 |
9.0K |
3 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
45
|
9.0K
|
3
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Positive results received for Emyrias MDMA-inspired program
|
|
Billyandpop
|
45 |
9.0K |
2 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
45
|
9.0K
|
2
|
|
ASX - By Stock
|
S2R |
Re:
Ann: Multiple new conductors identified at Polar Bear Project
|
|
Billyandpop
|
33 |
15K |
5 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
33
|
15K
|
5
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Positive results received for Emyrias MDMA-inspired program
|
|
Billyandpop
|
45 |
9.0K |
3 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
45
|
9.0K
|
3
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Positive results received for Emyrias MDMA-inspired program
|
|
Billyandpop
|
45 |
9.0K |
7 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
45
|
9.0K
|
7
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Positive results received for Emyrias MDMA-inspired program
|
|
Billyandpop
|
45 |
9.0K |
7 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
45
|
9.0K
|
7
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Emyria receives ethics approval for EMD-RX5 Phase 3 trial
|
|
Billyandpop
|
21 |
5.1K |
3 |
17/08/22 |
17/08/22 |
ASX - By Stock
|
21
|
5.1K
|
3
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Emyria receives ethics approval for EMD-RX5 Phase 3 trial
|
|
Billyandpop
|
21 |
5.1K |
10 |
17/08/22 |
17/08/22 |
ASX - By Stock
|
21
|
5.1K
|
10
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Emyria receives ethics approval for EMD-RX5 Phase 3 trial
|
|
Billyandpop
|
21 |
5.1K |
3 |
16/08/22 |
16/08/22 |
ASX - By Stock
|
21
|
5.1K
|
3
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Preclinical studies initiated for MDMA-inspired analogues
|
|
Billyandpop
|
22 |
5.3K |
3 |
15/08/22 |
15/08/22 |
ASX - By Stock
|
22
|
5.3K
|
3
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Preclinical studies initiated for MDMA-inspired analogues
|
|
Billyandpop
|
22 |
5.3K |
1 |
15/08/22 |
15/08/22 |
ASX - By Stock
|
22
|
5.3K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Preclinical studies initiated for MDMA-inspired analogues
|
|
Billyandpop
|
22 |
5.3K |
2 |
15/08/22 |
15/08/22 |
ASX - By Stock
|
22
|
5.3K
|
2
|
|
ASX - By Stock
|
S2R |
Re:
Ann: Multiple new conductors identified at Polar Bear Project
|
|
Billyandpop
|
33 |
15K |
6 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
33
|
15K
|
6
|
|
ASX - By Stock
|
GAL |
Re:
Ann: New Assays Confirm Consistent Rhodium in Drilling
|
|
Billyandpop
|
241 |
76K |
2 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
241
|
76K
|
2
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Preclinical studies initiated for MDMA-inspired analogues
|
|
Billyandpop
|
22 |
5.3K |
6 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
22
|
5.3K
|
6
|
|
ASX - By Stock
|
S2R |
Re:
Ann: Multiple new conductors identified at Polar Bear Project
|
|
Billyandpop
|
33 |
15K |
3 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
33
|
15K
|
3
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Emyria expands drug candidate library inspired by MDMA
|
|
Billyandpop
|
9 |
3.2K |
3 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
9
|
3.2K
|
3
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Emyria expands drug candidate library inspired by MDMA
|
|
Billyandpop
|
9 |
3.2K |
3 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
9
|
3.2K
|
3
|
|
ASX - By Stock
|
S2R |
Re:
Ann: Greater Fosterville Project Update
|
|
Billyandpop
|
51 |
39K |
4 |
19/07/22 |
19/07/22 |
ASX - By Stock
|
51
|
39K
|
4
|
|
ASX - By Stock
|
EMD |
Re:
Ann: EMD-RX5 demonstrates excellent safety and bioavailability
|
|
Billyandpop
|
94 |
27K |
0 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
94
|
27K
|
0
|
|
ASX - By Stock
|
S2R |
Re:
Ann: Greater Fosterville Project Update
|
|
Billyandpop
|
51 |
39K |
3 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
51
|
39K
|
3
|
|
ASX - By Stock
|
EMD |
Re:
Ann: EMD-RX5 demonstrates excellent safety and bioavailability
|
|
Billyandpop
|
94 |
27K |
4 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
94
|
27K
|
4
|
|
ASX - By Stock
|
GAL |
Re:
Ann: Drilling Intersects Extensive Mineralisation at Callisto
|
|
Billyandpop
|
541 |
182K |
6 |
13/07/22 |
13/07/22 |
ASX - By Stock
|
541
|
182K
|
6
|
|
ASX - By Stock
|
EMD |
Re:
general talk
|
|
Billyandpop
|
345 |
119K |
1 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
345
|
119K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
Ann: EMD-RX5 demonstrates excellent safety and bioavailability
|
|
Billyandpop
|
94 |
27K |
3 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
94
|
27K
|
3
|
|
ASX - By Stock
|
EMD |
Re:
Ann: EMD-RX5 demonstrates excellent safety and bioavailability
|
|
Billyandpop
|
94 |
27K |
6 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
94
|
27K
|
6
|
|
ASX - By Stock
|
EMD |
Re:
Ann: EMD-RX5 demonstrates excellent safety and bioavailability
|
|
Billyandpop
|
94 |
27K |
0 |
15/06/22 |
15/06/22 |
ASX - By Stock
|
94
|
27K
|
0
|
|
ASX - By Stock
|
EMD |
Re:
Ann: EMD-RX5 demonstrates excellent safety and bioavailability
|
|
Billyandpop
|
94 |
27K |
6 |
15/06/22 |
15/06/22 |
ASX - By Stock
|
94
|
27K
|
6
|
|
ASX - By Stock
|
EMD |
Re:
Ann: EMD-RX5 demonstrates excellent safety and bioavailability
|
|
Billyandpop
|
94 |
27K |
0 |
10/06/22 |
10/06/22 |
ASX - By Stock
|
94
|
27K
|
0
|
|
ASX - By Stock
|
EMD |
Re:
Ann: EMD-RX5 demonstrates excellent safety and bioavailability
|
|
Billyandpop
|
94 |
27K |
1 |
10/06/22 |
10/06/22 |
ASX - By Stock
|
94
|
27K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
Ann: EMD-RX5 demonstrates excellent safety and bioavailability
|
|
Billyandpop
|
94 |
27K |
7 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
94
|
27K
|
7
|
|
ASX - By Stock
|
GAL |
Re:
Ann: Assays Confirm Discovery with Drilling Set to Resume
|
|
Billyandpop
|
238 |
130K |
4 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
238
|
130K
|
4
|
|
ASX - By Stock
|
GAL |
Re:
Ann: Assays Confirm Discovery with Drilling Set to Resume
|
|
Billyandpop
|
238 |
130K |
1 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
238
|
130K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
Ann: EMD-RX5 demonstrates excellent safety and bioavailability
|
|
Billyandpop
|
94 |
27K |
6 |
25/05/22 |
25/05/22 |
ASX - By Stock
|
94
|
27K
|
6
|
|
ASX - By Stock
|
EMD |
Re:
Ann: EMD-RX5 demonstrates excellent safety and bioavailability
|
|
Billyandpop
|
94 |
27K |
1 |
25/05/22 |
25/05/22 |
ASX - By Stock
|
94
|
27K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
Ann: EMD-RX5 demonstrates excellent safety and bioavailability
|
|
Billyandpop
|
94 |
27K |
2 |
25/05/22 |
25/05/22 |
ASX - By Stock
|
94
|
27K
|
2
|
|
ASX - By Stock
|
EMD |
Re:
Ann: EMD-RX5 demonstrates excellent safety and bioavailability
|
|
Billyandpop
|
94 |
27K |
2 |
25/05/22 |
25/05/22 |
ASX - By Stock
|
94
|
27K
|
2
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Trading Halt
|
|
Billyandpop
|
17 |
5.6K |
4 |
23/05/22 |
23/05/22 |
ASX - By Stock
|
17
|
5.6K
|
4
|
|
ASX - By Stock
|
S2R |
Re:
Ann: Sale of Keulakkopaa Licence in Finland
|
|
Billyandpop
|
2 |
1.9K |
1 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
2
|
1.9K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Further positive MDMA analogue screening results received
|
|
Billyandpop
|
31 |
7.8K |
3 |
18/05/22 |
18/05/22 |
ASX - By Stock
|
31
|
7.8K
|
3
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Further positive MDMA analogue screening results received
|
|
Billyandpop
|
31 |
7.8K |
5 |
18/05/22 |
18/05/22 |
ASX - By Stock
|
31
|
7.8K
|
5
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Further positive MDMA analogue screening results received
|
|
Billyandpop
|
31 |
7.8K |
2 |
17/05/22 |
17/05/22 |
ASX - By Stock
|
31
|
7.8K
|
2
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Further positive MDMA analogue screening results received
|
|
Billyandpop
|
31 |
7.8K |
2 |
17/05/22 |
17/05/22 |
ASX - By Stock
|
31
|
7.8K
|
2
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Further positive MDMA analogue screening results received
|
|
Billyandpop
|
31 |
7.8K |
1 |
16/05/22 |
16/05/22 |
ASX - By Stock
|
31
|
7.8K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Further positive MDMA analogue screening results received
|
|
Billyandpop
|
31 |
7.8K |
4 |
16/05/22 |
16/05/22 |
ASX - By Stock
|
31
|
7.8K
|
4
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Further positive MDMA analogue screening results received
|
|
Billyandpop
|
31 |
7.8K |
1 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
31
|
7.8K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Further positive MDMA analogue screening results received
|
|
Billyandpop
|
31 |
7.8K |
0 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
31
|
7.8K
|
0
|
|